eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
6/2018
vol. 35
 
Share:
Share:
more
 
 
abstract:
Letter to the Editor

Lichen sclerosus as a clinical problem

Renata Przybylska, Katarzyna Plagens-Rotman, Krystyna Jaracz, Zygmunt Adamski, Magdalena Czarnecka-Operacz

Adv Dermatol Allergol 2018; XXXV (6): 644-648
Online publish date: 2018/08/13
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Lichen sclerosus (LS) is a chronic skin disease, mainly diagnosed among women during the postmenopausal period, localized within the genital area [1–3].
The etiopathogenesis of LS is not fully understood, however it seems that the genetic and autoimmune background may have the strongest influence on its development. The relationship with injuries, hormonal disorders, and chronic irritation of the genitals is also suggested [4–9].
For skin lesions located in the area of the vulva, the most common symptoms experienced by patients are itching, skin burns and pain. From the therapeutic point of view, this usually involves antihistaminic and sedative therapy, as well as topical treatment with corticosteroids.
The clinical picture of LS is characterized by swelling of the vulva, which in the course of the disease becomes indurated and inflamed. Further on, it leads to reduction of skin flexibility, the labia are reduced, and the vaginal opening is narrowed. In addition, fissures may appear within the area of the posterior commissure [10].
Treatment of LS is based on the topical use of the corticosteroids twice a day for up to 4 weeks, followed by 1–2 times per week, as well as topical calcineurin inhibitors, retinoids and topical hormonal medications (ointments containing estrogens and progesterone). Furthermore, phototherapy and photodynamic therapy are also suggested [11–13].
The aim of this study is to present three case reports of women diagnosed with lichen sclerosus and a brief review of contemporary therapeutic approaches.
Case 1: A 70-year-old woman was treated in the Department of Dermatology, Poznan University of Medical Sciences, due to the exacerbation in the course of the limited systemic sclerosis and lichen sclerosus previously confirmed by the skin biopsy. The course of the disease was relatively long as it started 20 years before. The patient was hospitalized several times – last time in February 2014. Initially lesions with porcelain-white spots of inflammation were recorded within the thorax, axilla, groin and vulva (Figures 1 A–C). Within about a month, further lesions developed on the anterior abdominal area with clinical characteristics of hemorrhagic morphological-type blisters. A scattered porcelain-white sclerosis was observed on hospital admission. The patient reported intense itching sensation in skin lesions, general weakness, and constant hands tremor. Procaine penicillin (10...


View full text...
references:
Lavorato FG, Nery NS, Bomm L, et al. What is your diagnosis? Case for diagnosis. An Bras Dermatol 2013; 2: 29-8.
Thibaudeau S, Luc M. Clitoroplasty: a blunt technique for patients with lichen sclerosis. J Plast Reconstr Aesthet Surg 2013; 66: e298-9.
Higgins CA, Cruickshank ME. A population-based case-control study of aetiological factors associated with vulval lichen sclerosus. J Obstet Gynaecol 2012; 32: 271-5.
Bhargava K, Lewis FM. Lichen sclerosus occurring on vaginal mucosa secondary to uterine prolapse. J Obstet Gynaecol 2013; 33: 319-20.
Hadas E, Żerdzińska AA, Norek N, et al. Multifocal lichen sclerosus. Case report. Przegl Dermatol 2015; 102: 28-32.
Edmonds EV, Hunt S, Hawkins D, et al. Clinical parameters in male genital lichen sclerosus: a case series of 329 patients. J Eur Acad Dermatol Venereol 2012; 26: 730-7.
Bjekić M, Šipetić S, Marinković J. Risk factors for genital lichen sclerosus in men. Br J Dermatol 2011; 164: 325-9.
Kreuter A, Wischnewski J, Terras S, et al. Coexistence of lichen sclerosus and morphea: a retrospective analysis of 472 patients with localized scleroderma from a German tertiary referral center. J Am Acad Dermatol 2012; 67: 1157-62.
Kreuter A, Kryvosheyeva Y, Terras S, et al. Association of autoimmune diseases with lichen sclerosus in 532 male and female patients. Acta Derm Venereol 2013; 93: 238-41.
Olek-Hrab K, Jenerowicz D, Osmola-Mańkowska A, et al. Selected vulvar dermatoses. Ginekol Pol 2013; 84: 959-65.
Fistarol SK, Itin PH. Diagnosis and treatment of lichen sclerosus. Am J Clin Dermatol 2013; 14: 27-47.
Goldstein A, Creasey A, Pfau R, et al. A double-bind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus. J Am Acad 2011; 64: e99-104.
Przytocka-Sadowska A, Dańczak-Pazdrowska A, Szewczyk A, et al. Treatment of genital lichen sclerosus in women – review. Ginekol Pol 2012; 83: 458-61.
Neill SM, Lewis FM, Tatnall FM, Cox NH. British Association of Dermatologists’ guidelines for the management of lichen sclerosus 2010. Br J Dermatol 2010; 163: 672-82.
Virgili A, Minghetti S, Borghi A, Corazza M. Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: preliminary results of a randomized study. Br J Dermatol 2013; 168: 1316-24.
Virgili A, Borghi A, Minghetti S, Corazza M. Mometasone fuoroate 0.1% ointment in the treatment of vulvar lichen sclerosus: a study of efficacy and safety on a large cohort of patients. J Eur Acad Dermatol Venereol 2013; 23: 189-94.
Lefevre C, Hoffstetter S, Meyer S, et al. Management of lichen sclerosus with triamcinolone ointment: effectiveness in reduction of patient symptom scores. J Low Genit Tract Dis 2011; 15: 205-9.
Kirtschig G, Becker K, Günthert A, et al. Evidence-based (S3) guideline on (anogenital) lichen sclerosus. J Eur Acad Dermatol Venereol 2015; 10: e1-43.
Kim G, Park H, Kim H, et al. Topical tacrolimus ointment for the treatment of lichen sclerosus, comparing genital and extragenital involvement. J Dermatol 2012; 39: 145-50.
Kauppila S, Kotila V, Knuuti E, et al. The effect of topical pimecrolimus on inflammatory infiltrate in vulvar lichen sclerosus. Am J Obstet Gynecol 2010; 202: 181e1-4.
Nissi R, Eriksen H, Risteli J, et al. Pimecrolimus cream 1% in the treatment of lichen sclerosus. Gynecol Obstet Invest 2007; 63: 151-4.
Kirtschig G. Lichen sclerosus – presentation, diagnosis and management. Dtsch Arztebl Int 2016; 113: 337-43.
Virgili A, Minghetti S, Borghi A, Corazza M. Long-term maintenance therapy for vulvar lichen sclerosus: the results of a randomized study comparing topical vitamin E with an emollient. Eur J Dermatol 2013; 23: 189-94.
Haefner HK, Aldrich NZ, Dalton VK, et al. The impact of vulvar lichen sclerosus on sexual dysfunction. J Womens Health 2014; 23: 765-70.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe